{"id":16789,"date":"2025-11-13T09:44:49","date_gmt":"2025-11-13T09:44:49","guid":{"rendered":"https:\/\/qiraatafrican.com\/fr\/?p=16789"},"modified":"2025-11-13T09:44:49","modified_gmt":"2025-11-13T09:44:49","slug":"des-chercheurs-gabonais-testent-un-traitement-antipaludique-prometteur-en-dose-unique","status":"publish","type":"post","link":"https:\/\/qiraatafrican.com\/fr\/16789\/des-chercheurs-gabonais-testent-un-traitement-antipaludique-prometteur-en-dose-unique\/","title":{"rendered":"Des chercheurs gabonais testent un traitement antipaludique prometteur en dose unique"},"content":{"rendered":"<p>Des m\u00e9decins gabonais affirment qu&rsquo;un nouveau traitement antipaludique en dose unique pourrait contribuer \u00e0 freiner la r\u00e9sistance croissante du paludisme aux m\u00e9dicaments existants.<\/p>\n<p>Sous la direction du Dr Ghyslain Mombo-Ngoma, au Centre de Recherche M\u00e9dicale de Lambar\u00e9n\u00e9, des chercheurs ont test\u00e9 un traitement unique combinant quatre antipaludiques largement disponibles\u00a0: la sulfadoxine, la pyrim\u00e9thamine, l&rsquo;art\u00e9sunate et la pyronaridine. Ce nouveau m\u00e9dicament a permis d&rsquo;\u00e9liminer les parasites du paludisme chez 93\u00a0% des patients, un r\u00e9sultat comparable \u00e0 celui du traitement standard de trois jours.<\/p>\n<p>\u00ab\u00a0Face \u00e0 l&rsquo;augmentation de la mortalit\u00e9 due au paludisme, nous avons besoin de solutions imm\u00e9diates\u00a0\u00bb, a d\u00e9clar\u00e9 le Dr Mombo-Ngoma. \u00ab\u00a0Nous nous sommes donc dit\u00a0: pourquoi ne pas optimiser l&rsquo;utilisation des antipaludiques existants\u00a0?\u00bb<\/p>\n<p>Pour de nombreux Gabonais, le paludisme demeure un combat permanent. Julicia Nfono, habitante de Libreville, t\u00e9moigne que la maladie r\u00e9cidive malgr\u00e9 les mesures pr\u00e9ventives. \u00ab\u00a0M\u00eame si nous utilisons des moustiquaires et nous prot\u00e9geons de l&rsquo;eau contamin\u00e9e, tant qu&rsquo;il y a des moustiques, le paludisme revient\u00a0\u00bb, d\u00e9plore-t-elle.<\/p>\n<p>D\u2019apr\u00e8s le Programme national de lutte contre le paludisme du Gabon, le pays a enregistr\u00e9 plus de 154\u00a0000 cas en 2024, les enfants de moins de cinq ans \u00e9tant les plus touch\u00e9s. Hugues Ronel Essanga Ngomo, responsable du programme, qualifie le paludisme de \u00ab\u00a0probl\u00e8me majeur de sant\u00e9 publique\u00a0\u00bb.<\/p>\n<p>L\u2019administration d\u2019une dose unique pourrait contribuer \u00e0 am\u00e9liorer l\u2019observance du traitement, \u00e0 r\u00e9duire la r\u00e9sistance aux antipaludiques et \u00e0 faciliter l\u2019acc\u00e8s aux soins dans les communaut\u00e9s africaines les plus touch\u00e9es.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Des m\u00e9decins gabonais affirment qu&rsquo;un nouveau traitement antipaludique en dose unique pourrait contribuer \u00e0 freiner la r\u00e9sistance croissante du paludisme aux m\u00e9dicaments existants. Sous la direction du Dr Ghyslain Mombo-Ngoma, au Centre de Recherche M\u00e9dicale de Lambar\u00e9n\u00e9, des chercheurs ont test\u00e9 un traitement unique combinant quatre antipaludiques largement disponibles\u00a0: la sulfadoxine, la pyrim\u00e9thamine, l&rsquo;art\u00e9sunate et [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16791,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"iawp_total_views":30,"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","override":[{"template":"1","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"topbottom","share_float_style":"share-monocrhome","show_share_counter":"1","show_featured":"1","show_post_meta":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"0","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","number_popup_post":"1","show_post_related":"1","show_inline_post_related":"1"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0"},"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"footnotes":""},"categories":[41,8],"tags":[],"class_list":["post-16789","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-afrique-centrale","category-societe-africaine"],"_links":{"self":[{"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/posts\/16789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/comments?post=16789"}],"version-history":[{"count":0,"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/posts\/16789\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/media\/16791"}],"wp:attachment":[{"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/media?parent=16789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/categories?post=16789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qiraatafrican.com\/fr\/wp-json\/wp\/v2\/tags?post=16789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}